Table 2 Comparison of outcomes based on baseline characteristics and comorbidities both pre and during COVID-19 pandemic

Age, mean (SD)

66.5 (14.9)

66.2 (14.8)

66.4 (14.8)

0.913

Female gender

90 (64.3)

20 (57.1)

110 (62.9)

0.557

Acute ischemic stroke

74 (52.9)

10 (28.6)

84 (48.0)

0.027

Intracerebral hemorrhage

32 (22.9)

11 (31.4)

43 (24.6)

0.027

Undetermined stroke type¹

24 (17.1)

11 (31.4)

35 (20.0)

0.027

Time to outcome, mean (SD)²

60.9 (212.9)

3.1 (2.8)

48.9 (190.8)

0.127

Complete physical examination done

111 (79.3)

22 (62.9)

133 (76.0)

0.07

Admitted in 2019

41 (29.3)

12 (34.3)

53 (30.3)

0.711

Comorbidities

History of stroke

13 (9.3)

10 (28.6)

23 (13.1)

0.005

History of transient ischemic attack

10 (7.1)

8 (22.9)

18 (10.3)

0.01

History of smoking

37 (26.4)

10 (28.6)

47 (26.9)

0.903

History of alcohol use

54 (38.6)

17 (48.6)

71 (40.6)

0.342

Diabetes

21 (15.0)

8 (22.9)

29 (16.6)

0.388

Hypertension

80 (57.1)

23 (65.7)

103 (58.9)

0.466

History of Atrial Fibrillation

4 (2.9)

4 (11.4)

8 (4.6)

0.088

Prior myocardial infarction

7 (5.0)

4 (11.4)

11 (6.3)

0.329

History of Dyslipidemia

133 (95.0)

30 (85.7)

163 (93.1)

0.426

Living with HIV

11 (7.9)

2 (5.7)

13 (7.4)

1

Current use of anticoagulant therapy

10 (7.1)

8 (22.9)

18 (10.3)

0.016